123 related articles for article (PubMed ID: 6767771)
21. C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection.
Terkawi MA; Zhang G; Jia H; Aboge G; Goo YK; Nishikawa Y; Yokoyama N; Igarashi I; Kawazu SI; Fujisaki K; Xuan X
Parasite Immunol; 2008; 30(6-7):365-70. PubMed ID: 18533933
[TBL] [Abstract][Full Text] [Related]
22. The role of complement in glomerulonephritis.
Simpson IJ
Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
[No Abstract] [Full Text] [Related]
23. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte-bound complement components in health and disease.
Garratty G
Prog Clin Biol Res; 1980; 43():133-55. PubMed ID: 6999500
[No Abstract] [Full Text] [Related]
25. Anemia and thrombocytopenia from Corynebacterium parvum-stimulated resistance against malaria, trypanosomiasis, and babesiosis.
Cox HW; Saleh SM
J Parasitol; 1983 Aug; 69(4):654-9. PubMed ID: 6355427
[TBL] [Abstract][Full Text] [Related]
26. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
Moore FD; Fearon DT; Austen KF
J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
[No Abstract] [Full Text] [Related]
27. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
29. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
30. [Complement system in glomerulonephritis. II. Detailed aspects].
Bodalski J; Narebska E; Jerzmanowski A
Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
[No Abstract] [Full Text] [Related]
31. Lack of binding of human C3, in its native state, to C3b receptors.
Berger M; Gaither TA; Hammer CH; Frank MM
J Immunol; 1981 Oct; 127(4):1329-34. PubMed ID: 7276560
[No Abstract] [Full Text] [Related]
32. [The complement system: a fascinating biological chain of events].
Porcel JM; Vergani D
Med Clin (Barc); 1993 Mar; 100(11):428-35. PubMed ID: 8499033
[No Abstract] [Full Text] [Related]
33. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
Kaneko I; Fearon DT; Austen KF
J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
[No Abstract] [Full Text] [Related]
34. Studies on the role of complement in the in vitro invasion of bovine erythrocytes by Babesia bovis.
Levy MG; Kakoma I; Clabaugh G; Ristic M
Rev Elev Med Vet Pays Trop; 1986; 39(3-4):317-22. PubMed ID: 3659482
[No Abstract] [Full Text] [Related]
35. Opinion paper: Stimulation of complement amplification or activation of the alternative pathway of complement?
Lutz HU; Fumia S; Schurtenberger C; Alaia V
Mol Immunol; 2007 Sep; 44(16):3862-5. PubMed ID: 17768104
[TBL] [Abstract][Full Text] [Related]
36. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
37. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
38. C3 receptors, complement deficiency and SLE.
Walport M; Lachmann P
Br J Rheumatol; 1984 Feb; 23(1):3-5. PubMed ID: 6697070
[No Abstract] [Full Text] [Related]
39. Action of chlorogenic acid on the complement system.
Ejzemberg R; Da Silva MH; Pinto L; Mors WB
An Acad Bras Cienc; 1999; 71(2):273-7. PubMed ID: 10412494
[TBL] [Abstract][Full Text] [Related]
40. The alternative pathway of complement: a pattern recognition system.
Zipfel PF; Mihlan M; Skerka C
Adv Exp Med Biol; 2007; 598():80-92. PubMed ID: 17892206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
